Elucidation of DnaE as the Antibacterial Target of the Natural Product, Nargenicin
Ronald E. Painter(Merck & Co., Inc., Rahway, NJ, USA (United States)), Katherine Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Edward DiNunzio(Merck & Co., Inc., Rahway, NJ, USA (United States)), Francisca Vicente(Fundación Medina), Fred Racine(Merck & Co., Inc., Rahway, NJ, USA (United States)), Karen Dorso(Merck & Co., Inc., Rahway, NJ, USA (United States)), Olga Genilloud(Fundación Medina), Gregory C. Adam(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marta Arocho(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bakela Nare(Scynexis (United States)), Nichelle Hairston(Merck & Co., Inc., Rahway, NJ, USA (United States)), Milton L. Hammond(Merck & Co., Inc., Rahway, NJ, USA (United States)), Douglas Wisniewski(Merck & Co., Inc., Rahway, NJ, USA (United States)), Maryann Powles(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jing Su(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert G. K. Donald(Merck & Co., Inc., Rahway, NJ, USA (United States)), Charles Gill(Merck & Co., Inc., Rahway, NJ, USA (United States)), David B. Olsen, Michael Goetz(Universität Ulm), Xiao Li(Chinese Academy of Sciences)
Cited by 40
Related Papers
New developments in RiPP discovery, enzymology and engineering
|Natural Product Reports|2020|793
ISLES 2015 - A public evaluation benchmark for ischemic stroke lesion segmentation from multispectral MRI
|Medical Image Analysis|2016|531
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502